Healthpeak Properties, Inc. (NYSE:DOC) Shares Sold by Duff & Phelps Investment Management Co.

Duff & Phelps Investment Management Co. lowered its stake in shares of Healthpeak Properties, Inc. (NYSE:DOC - Free Report) by 1.9% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 637,478 shares of the real estate investment trust's stock after selling 12,610 shares during the quarter. Duff & Phelps Investment Management Co. owned about 0.09% of Healthpeak Properties worth $12,922,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also recently modified their holdings of DOC. Thrivent Financial for Lutherans purchased a new position in shares of Healthpeak Properties in the third quarter worth $1,880,000. Citigroup Inc. purchased a new stake in Healthpeak Properties during the 3rd quarter valued at about $14,154,000. Cerity Partners LLC acquired a new position in shares of Healthpeak Properties in the third quarter valued at about $5,051,000. Swedbank AB purchased a new position in shares of Healthpeak Properties in the third quarter worth about $1,832,000. Finally, Loomis Sayles & Co. L P acquired a new stake in shares of Healthpeak Properties during the third quarter worth about $70,000. 93.57% of the stock is owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

DOC has been the subject of a number of recent research reports. Wells Fargo & Company reduced their price target on shares of Healthpeak Properties from $23.00 to $22.00 and set an "equal weight" rating for the company in a research report on Tuesday, December 10th. Wedbush cut their target price on shares of Healthpeak Properties from $27.00 to $24.00 and set an "outperform" rating for the company in a report on Friday, February 14th. StockNews.com upgraded shares of Healthpeak Properties from a "sell" rating to a "hold" rating in a research report on Saturday, March 22nd. Robert W. Baird decreased their price objective on shares of Healthpeak Properties from $25.00 to $24.00 and set an "outperform" rating for the company in a research report on Tuesday, February 11th. Finally, Scotiabank dropped their target price on Healthpeak Properties from $24.00 to $23.00 and set a "sector outperform" rating on the stock in a research report on Friday, February 28th. Four analysts have rated the stock with a hold rating, ten have issued a buy rating and one has issued a strong buy rating to the company's stock. Based on data from MarketBeat, the stock currently has an average rating of "Moderate Buy" and a consensus price target of $23.92.

Remove Ads

Healthpeak Properties Trading Down 0.4 %

NYSE:DOC traded down $0.09 during trading hours on Tuesday, hitting $20.14. The company had a trading volume of 1,448,549 shares, compared to its average volume of 4,848,536. Healthpeak Properties, Inc. has a 1 year low of $17.80 and a 1 year high of $23.26. The company has a current ratio of 1.35, a quick ratio of 1.35 and a debt-to-equity ratio of 0.96. The company has a 50-day moving average of $20.22 and a 200 day moving average of $21.08. The company has a market cap of $14.09 billion, a P/E ratio of 57.82, a P/E/G ratio of 2.17 and a beta of 1.14.

Healthpeak Properties Increases Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Wednesday, February 26th. Investors of record on Friday, February 14th were given a dividend of $0.305 per share. This represents a $1.22 dividend on an annualized basis and a dividend yield of 6.06%. This is an increase from Healthpeak Properties's previous quarterly dividend of $0.30. The ex-dividend date was Friday, February 14th. Healthpeak Properties's dividend payout ratio (DPR) is presently 348.57%.

Healthpeak Properties Company Profile

Healthpeak Properties, Inc is a fully integrated real estate investment trust (REIT) and S&P 500 company. Healthpeak owns, operates, and develops high-quality real estate for healthcare discovery and delivery.